Ask Warren

IntoCell

287840 · KOSDAQ · ₩287840 · 인투셀

₩15,980▼ ₩120 (0.75%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

IntoCell287840· Biotech & PharmaInitiation

IntoCell: Loss-Making Biotech Down 61.7% Over a Year, Trading at 11.4x Book

IntoCell, a KOSDAQ-listed biotech listed in May 2025, closed at ₩14,890 on 2026-10-16, down 61.7% over one year and near its 52-week low of ₩13,050. Revenue is small at ₩3.2B over the trailing twelve months, losses continue, and the model estimate is far below the share price.

Oct 18, 20260 views

Read the research report

Report history

  1. Oct 18, 2026InitiationStart of coverage (reader request)IntoCell: Loss-Making Biotech Down 61.7% Over a Year, Trading at 11.4x Book

This is not financial advice. The report does not recommend buying or selling anything.

Also known as: IntoCell / 인투셀 / 287840 / KRX:287840

Source: KRX statistical information